vimarsana.com

Page 12 - பத்திரங்கள் வர்க்கம் நடவடிக்கை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

XL SHAREHOLDER DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against XL Fleet Corp

NEW YORK, March 15, 2021 (GLOBE NEWSWIRE) Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of XL Fleet Corp. ("XL Fleet" or the "Company") (NYSE: XL) from October 2, 2020 through March 2, 2021 (the “Class Period”). The lawsuit filed in the United States District Court for the Southern District of New York alleges violations of the Securities Exchange Act of 1934. If you purchased XL Fleet securities, and/or would like to discuss your legal rights and options please visit XL Fleet Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com The complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements, as well as failed to disclose to in

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Notifies Athenex (ATNX) Investors of Filing of Securities Fraud Lawsuit, Encourages Investors with Losses to Contact Its Attorneys

SAN FRANCISCO, March 15, 2021 (GLOBE NEWSWIRE) Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. Class Period: Aug. 7, 2019 – Feb. 26, 2021Lead Plaintiff Deadline: May 3, 2021Visit: www.hbsslaw.com/investor-fraud/ATNX Contact An Attorney Now: ATNX@hbsslaw.com 844-916-0895 Athenex, Inc. (NASDAQ: ATNX) Securities Class Action: The Complaint alleges that throughout the Class Period, Defendants made false statements and omissions about its flagship drug candidate, an oral paclitaxel and encequidar for the treatment of metastatic breast cancer. Specifically, Defendants misrepresented and concealed that: (i) the data included in the Oral Paclitaxel plus Encequidar New Drug Application presented a safety risk to patients; (ii) there was uncertainty over the results of the primary endpoint of objective response rate (ORR), which might have introduced unmeasured bias and influence on the blinded independent central review (BIC

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Renewable Energy Group, Inc Investors with Large Losses to Secure Counsel Before Important Deadline

NEW YORK, NY / ACCESSWIRE / March 15, 2021 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Renewable Energy Group, Inc. (NASDAQ:REGI) between May 3, 2018 and February 25, 2021, inclusive (the "Class Period").

EH LOSS ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages EHang Holdings Limited Investors with Large Losses to Secure Counsel Before Important Deadline

NEW YORK, NY / ACCESSWIRE / March 15, 2021 /WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of EHang Holdings Limited (NASDAQ:EH) between December 12, 2019 and February 16, 2021, inclusive (the "Class Period"), of the important April 19, 2021 lead plaintiff deadline.SO WHAT: If you purchased EHang securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.